Document Classification

Section Type: RESULTS

Text: The salbutamol doses to be delivered by the Diskus to achieve recovery times for FVC, FEV (1) and volume-adjusted mid-expiratory flow similar to those obtained with 200 microg salbutamol administered via the pMDI + Volumatic were 558 (95 % CI 537, 579) microg, 395 (95 % CI 388, 404) microg and 404 (95 % CI 393, 415) microg, respectively, and corresponded to relative potencies of 2. 79 (95 % CI 2. 68, 2. 90), 1. 98 (95 % CI 1. 94, 2. 02), and 2. 02 (95 % CI 1. 96, 2. 07).